Reading Time: 3 minutes
Introduction
Parkinson’s disease (PD) is one of the fastest-growing neurological disorders, affecting millions worldwide. Despite its prevalence, diagnosing Parkinson’s remains challenging due to symptom variability and the lack of a definitive …
Read MoreReading Time: 3 minutes
Parkinson’s disease is a complex neurodegenerative disorder that requires ongoing advances in pharmaceutical research to improve patient outcomes. Recent developments by PreveCeutical have focused on the Sol-Gel N2B platform, a …
Reading Time: 3 minutes
Keywords: Parkinson’s disease, non-motor symptoms, meaning in life, loneliness, demoralization, stigma, mental health, quality of life, depression, anxiety, apathy, social isolation, psychological well-being, caregiver burden, neuropsychiatric symptoms, emotional health, psychosocial …
Reading Time: 4 minutes
Parkinson’s disease (PD), motor symptom variability, MDS-UPDRS scale, day-to-day changes, clinically meaningful fluctuations, crossover design, continuous monitoring, wearable sensors, digital biomarkers, patient-centric approach, non-motor symptoms, reliability, clinical trials, disease management, …
Reading Time: 3 minutes
Parkinson’s disease (PD) is a neurodegenerative disorder that results from dopamine depletion in the brain. Traditional treatment relies heavily on levodopa (L-DOPA), the gold standard for managing motor symptoms. However, …
Read More